Lu Tang

Bridging the gap: neuroinflammation and the dawn of precision medicine in amyotrophic lateral sclerosis

Abstract Neuroinflammation is no longer a secondary feature of amyotrophic lateral sclerosis (ALS), but rather a disease-modifying process that actively shapes the motor neuron vulnerability from the earliest stages of pathology. Central and peripheral immune cells, including mic...